SlideShare ist ein Scribd-Unternehmen logo
1 von 22
MARKUSH FOR PATENT ANALYSIS
Steve Hajkowski
ChemAxon UGM Budapest 2013
THOMSON REUTERS MARKUSH DATA
• Indexing for 2.4 million patent families
– 1.6m Markush structures, re-drawn & stored in Thomson Reuters vmn
file format
– 1.98m specific compounds
– plus the corresponding DWPI records
– 28 patent issuing authorities covered
• backfile from 1978 for US, EP and WO patents
– covers pharmaceutical, agrochemical and general chemistry patents
• Indexed as part of the editorial process that creates Derwent World
Patents Index (DWPI)
– Informative English language titles & abstracts from worldwide patents
– Patent family listing, patent assignees
COVERAGE START DATES
Austria 1987 Korea 2008
Australia 1987 Malaysia 2010
Belgium 1987 Netherlands 1987
Brazil 2010 New Zealand 1987
Canada 1987 PCT/WO
1978 (Pharma); 1982 (Agro + Gen.
Chem.)
China 2008 Poland 2011
European Patents
1978 (Pharma); 1982 (Agro +
Gen. Chem.)
Russia 1993-1998 and 2010 to date
France
1961-1976 (FR-M); 1978
(Pharma); 1982 (Agro + Gen
Chem)
South Africa 1987
Germany
1980 (Pharma); 1983-84 and
1987 to date (Agro + Gen.
Chem.)
Spain 2010
Great Britain
1980 (Pharma); 1983-84 and
1987 to date (Agro + Gen.
Chem.)
Sweden 1987
Gulf Cooperation Council 2008 Switzerland 1987
India 2000 Thailand 2010
Ireland 1987 United States
1978 (Pharma); 1982 (Agro + Gen.
Chem.)
Japan 1987 Vietnam 2010
MARKUSH DATA ACCESS
• Markush structure data available alongside corresponding
specific compounds & DWPI records
• Load into ChemAxon’s JChem database tools
• Resulting solution gives access to full chemistry & patents
dataset
– data can be searched, enumerated & integrated into the
customer’s own systems & workflows
4
JCHEM MARKUSH BENEFITS
• Structure data displayed alongside high quality
patent summaries from DWPI
– includes abstract, patent assignee, patent family, activities
& mechanisms of action
• Time saving visualisation and enumeration
capabilities enable fast relevance analysis of hit
structures/patents
• Enumerated structures are in standard format
allowing easy integration with other chemistry
datasets/tools
USE CASES
• Novelty searching by IP departments
– Easy assessment of structural proximity of query structure
to hit Markush
• Screening of new structures against existing IP
• Potential use in white-space identification, patent
busting etc.
• Creation of libraries of specifics for use in other
systems
MARKUSH PATENT ANALYSIS
• What can analysis of Markush and DWPI patent data
tell us about global patenting trends in 2012?
• > 8000 patents claiming new pharmaceutical Markush
structures
• > 3700 patents claiming new non-pharma Markush
structures
MARKUSH PHARMA PATENTING
COMPANIES 2012
Number of patents Company
129 MERCK & CO
119 ROCHE
82 BAYER AG
60 ABBOTT
59 GLAXOSMITHKLINE
57 NOVARTIS
57 CENTRE NATIONAL RECHERCHE SCIENTIFIQUE
55 BOEHRINGER INGELHEIM
54 SANOFI AVENTIS
52 BRISTOL-MYERS SQUIBB
51 MERCK PATENT GMBH
42 JOHNSON & JOHNSON
41 ALLERGAN
39 TAKEDA PHARMA
37 PFIZER
30 COUNCIL SCI&IND RES INDIA
27 SHIONOGI
26 DAIICHI SANKYO
25 UNIV CALIFORNIA
MARKUSH PHARMA PATENTING
TERRITORIES IN 2012
MARKUSH CHEMICAL PATENTING
COMPANIES 2012
Number of patents Company
164 SUMITOMO CHEMICAL CO
90 BAYER CROPSCIENCE
82 BASF
65 MERCK PATENT GMBH
61 FUJI FILM CO
42 SEMICONDUCTOR ENERGY LAB
40 SYNGENTA
39 ROHM&HAAS ELECTRONIC MATERIALS KOREA
38 CANON KK
38 OCEANS KING LIGHTING SCI&TECHNOLOGY CO
37 IDEMITSU KOSAN CO LTD
36 DU PONT
34 HAIYANGWANG LIGHTING TECHNOLOGY CO LTD
34 NIPPON KAYAKU KK
34 POLITECHNIKA WROCLAWSKA
30 JNC CORP
28 KOREA RES INST CHEM TECHNOLOGY
27 TOSOH CORP
26 TIANJIN DEKAI CHEM LTD
MARKUSH CHEMICAL PATENTING
TERRITORIES IN 2012
MARKUSH CASE STUDY
• Analysis of all Markush patents claiming new
molecules containing the structure fragment below
– look at companies, timeframes, activities, inventors
SEARCH RESULTS
• A structure search of the Thomson Reuters data
generates hits from 122 patents, with hits found
back to 1988
SAMPLE HITS
New heterocyclic derivatives useful for treating cardiovascular
diseases,hypertension, ischemic heart disease,
atherosclerosis and metabolic syndrome
CTG PHARMA SRL WO2008122356A1 20081016
Novel benzyloxymethyl-4-chloro-imidazol
methyl-biphenyl-tetrazole group containing compound
useful for treating diseases associated withperoxisome
proliferator-activated receptor-gamma, e.g. diabetes and
angiocardiopathy
SHANGHAI AILISI MEDICINE SCI & TECHNOLOGY
WO2008110062A1 20080918
SAMPLE HITS
New 2-butyl-4-chloro-imidazol-5-yl-methyl ester
compound used for preparing drugs for prophylaxis
and/or treating high blood pressure or correlative
diseases including pulmonary arterial hypertension,
coronary heart disease and/or migraine
WANG J CN101475565A 20090708
Forming biphenyltetrazole derivatives useful to treat e.g.
stroke involves reacting 2-(trimethylsilyl)ethoxymethyl
protected biphenyltetrazole compounds with nucleophilic
reagent and subsequent deprotection ofprotecting group
SIMS SOC ITAL MEDICINALI SCANDICCI SRL
WO--2008012852A1
TOP 10 COMPANIES
Number of patents Company
17 MERCK & CO INC
8 NICOX SA
7 DU PONT DE NEMOURS & CO
7 KOTOBUKI SEIYAKU CO LTD
6 MERCK PATENT GMBH
4 NITROMED INC
4 TANABE SEIYAKU CO
4 THERAVANCE INC
3 DIPHARMA SPA
3 SANKYO CO LTD
TOP PATENT COUNTRIES
PATENTING TIMELINE
DRUG ACTIVITIES CLAIMED
% of Patents Activity
88 Hypotensive
64 Cardioactive
47 Renal active
43 Anti-cholesterol
43 Eye preparations
34 Circulatory active
32 Antipsychotic
30 Coronary dilator
28 Antimetabolite
27 Antiinflammatory
25 Enzyme inhibitor
TOP INVENTORS AT MERCK
Number of patents Inventor
9 LO M M
8 ALI A
6 ALMIRANTE N
5 STEFANINI S
4 BIONDI S
4 CHAKRAVARTY P K
4 FRANKLIN C
4 GREENLEE W J
4 NARGUND R P
4 PATCHETT A A
4 SEBHAT I K
SUMMARY
• Markush analysis allows us to view the chemistry
patent lansdcape
– broad view of trends for companies, countries etc
– narrower view for particular structure types
• shows which companies are active, trends over time, top
inventors, drug activities etc.
Thank you

Weitere ähnliche Inhalte

Andere mochten auch

EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...
EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...
EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...
ChemAxon
 
EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...
EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...
EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...
ChemAxon
 
EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...
EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...
EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...
ChemAxon
 

Andere mochten auch (16)

EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...
EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...
EUGM 2013 - Sergio H. Rotstein (Pfizer): What about the “big guys”? The emerg...
 
EUGM 2013 - Roland Knispel (ChemAxon) - Biologics at ChemAxon From Old Powerh...
EUGM 2013 - Roland Knispel (ChemAxon) - Biologics at ChemAxon From Old Powerh...EUGM 2013 - Roland Knispel (ChemAxon) - Biologics at ChemAxon From Old Powerh...
EUGM 2013 - Roland Knispel (ChemAxon) - Biologics at ChemAxon From Old Powerh...
 
EUGM 2013 - Attila Szabo (ChemAxon) - Collaborate and search in SharePoint wi...
EUGM 2013 - Attila Szabo (ChemAxon) - Collaborate and search in SharePoint wi...EUGM 2013 - Attila Szabo (ChemAxon) - Collaborate and search in SharePoint wi...
EUGM 2013 - Attila Szabo (ChemAxon) - Collaborate and search in SharePoint wi...
 
EUGM 2013 - Miklos Szabo (ChemAxon) - Recent Successful Discovery Strategies ...
EUGM 2013 - Miklos Szabo (ChemAxon) - Recent Successful Discovery Strategies ...EUGM 2013 - Miklos Szabo (ChemAxon) - Recent Successful Discovery Strategies ...
EUGM 2013 - Miklos Szabo (ChemAxon) - Recent Successful Discovery Strategies ...
 
EUGM 2013 - Anh Kiet Tran Minh (CNRS): French Academic Compound Library: the ...
EUGM 2013 - Anh Kiet Tran Minh (CNRS): French Academic Compound Library: the ...EUGM 2013 - Anh Kiet Tran Minh (CNRS): French Academic Compound Library: the ...
EUGM 2013 - Anh Kiet Tran Minh (CNRS): French Academic Compound Library: the ...
 
EUGM 2013 - Peter Englert, Peter Kovacs (ChemAxon) - The Next Generation of M...
EUGM 2013 - Peter Englert, Peter Kovacs (ChemAxon) - The Next Generation of M...EUGM 2013 - Peter Englert, Peter Kovacs (ChemAxon) - The Next Generation of M...
EUGM 2013 - Peter Englert, Peter Kovacs (ChemAxon) - The Next Generation of M...
 
EUGM 2013 - Michael Dippolito (Deltasoft): Great Migrations! – Approaches to ...
EUGM 2013 - Michael Dippolito (Deltasoft): Great Migrations! – Approaches to ...EUGM 2013 - Michael Dippolito (Deltasoft): Great Migrations! – Approaches to ...
EUGM 2013 - Michael Dippolito (Deltasoft): Great Migrations! – Approaches to ...
 
EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...
EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...
EUGM 2013 - Christopher Southan (TW2Informatics): Chemicalize.org, SureChemOp...
 
EUGM 2013 - Björn Windshügel (European ScreeningPort): Chemoinformatic tools ...
EUGM 2013 - Björn Windshügel (European ScreeningPort): Chemoinformatic tools ...EUGM 2013 - Björn Windshügel (European ScreeningPort): Chemoinformatic tools ...
EUGM 2013 - Björn Windshügel (European ScreeningPort): Chemoinformatic tools ...
 
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic MetabolismEUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
EUGM 2013 - Gyorgy Pirok (ChemAxon) - Prediction of Xenobiotic Metabolism
 
EUGM 2013 - Ian Berry, Bob Marmon (Evotec): Classification and analysis of 21...
EUGM 2013 - Ian Berry, Bob Marmon (Evotec): Classification and analysis of 21...EUGM 2013 - Ian Berry, Bob Marmon (Evotec): Classification and analysis of 21...
EUGM 2013 - Ian Berry, Bob Marmon (Evotec): Classification and analysis of 21...
 
EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...
EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...
EUGM 2013 - Bernd Rupp (FMP) Chemical Information systems: From compound coll...
 
EUGM 2013 - Jon Patterson (ChemAxon) ChemAxon Platform for Scientists
EUGM 2013 - Jon Patterson (ChemAxon) ChemAxon Platform for Scientists EUGM 2013 - Jon Patterson (ChemAxon) ChemAxon Platform for Scientists
EUGM 2013 - Jon Patterson (ChemAxon) ChemAxon Platform for Scientists
 
EUGM 2013 - Anna Tomin (ChemAxon) - Reaction Library Design
EUGM 2013 - Anna Tomin (ChemAxon) - Reaction Library DesignEUGM 2013 - Anna Tomin (ChemAxon) - Reaction Library Design
EUGM 2013 - Anna Tomin (ChemAxon) - Reaction Library Design
 
EUGM 2013 - Timea Polgar (ChemAxon) - 3D visualization for medicinal chemists
EUGM 2013 - Timea Polgar (ChemAxon) - 3D visualization for medicinal chemistsEUGM 2013 - Timea Polgar (ChemAxon) - 3D visualization for medicinal chemists
EUGM 2013 - Timea Polgar (ChemAxon) - 3D visualization for medicinal chemists
 
Anthony Trippe Harnessing the Power of Patent Analytics A Policy Maker's Pers...
Anthony Trippe Harnessing the Power of Patent Analytics A Policy Maker's Pers...Anthony Trippe Harnessing the Power of Patent Analytics A Policy Maker's Pers...
Anthony Trippe Harnessing the Power of Patent Analytics A Policy Maker's Pers...
 

Ähnlich wie EUGM 2013 - Steve Hajkowski (Thomson Reuters): Patent analytics - what can Markush data tell us?

Medical-Gas-Training-1.ppt Valuable information
Medical-Gas-Training-1.ppt Valuable informationMedical-Gas-Training-1.ppt Valuable information
Medical-Gas-Training-1.ppt Valuable information
fatahozil
 
ICIC 2013 New Product Introductions FIZ Karlsruhe
ICIC 2013 New Product Introductions FIZ KarlsruheICIC 2013 New Product Introductions FIZ Karlsruhe
ICIC 2013 New Product Introductions FIZ Karlsruhe
Dr. Haxel Consult
 
Master of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH GiudelinesMaster of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH Giudelines
omkarmandlik678
 
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...
Martin Krallinger
 
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIESSUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
Ritwik Parikh
 
Research aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzersResearch aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzers
Neel Terde
 
Research aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzersResearch aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzers
Neel Terde
 

Ähnlich wie EUGM 2013 - Steve Hajkowski (Thomson Reuters): Patent analytics - what can Markush data tell us? (20)

Medical-Gas-Training-1.ppt Valuable information
Medical-Gas-Training-1.ppt Valuable informationMedical-Gas-Training-1.ppt Valuable information
Medical-Gas-Training-1.ppt Valuable information
 
ICIC 2013 New Product Introductions FIZ Karlsruhe
ICIC 2013 New Product Introductions FIZ KarlsruheICIC 2013 New Product Introductions FIZ Karlsruhe
ICIC 2013 New Product Introductions FIZ Karlsruhe
 
Master of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH GiudelinesMaster of pharmacy... Pharmaceutics ICH Giudelines
Master of pharmacy... Pharmaceutics ICH Giudelines
 
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity ...
 
Patent Anlaysis Report - Miniature drug delivery systems
Patent Anlaysis Report - Miniature drug delivery systemsPatent Anlaysis Report - Miniature drug delivery systems
Patent Anlaysis Report - Miniature drug delivery systems
 
Feasibility Studies: Methanol Manufacturing
Feasibility Studies: Methanol ManufacturingFeasibility Studies: Methanol Manufacturing
Feasibility Studies: Methanol Manufacturing
 
Feasibility Studies: THF Manufacturing
Feasibility Studies: THF ManufacturingFeasibility Studies: THF Manufacturing
Feasibility Studies: THF Manufacturing
 
Economics of THF Production Processes
Economics of THF Production ProcessesEconomics of THF Production Processes
Economics of THF Production Processes
 
Feasibility Studies: Paracetamol Manufacturing
Feasibility Studies: Paracetamol ManufacturingFeasibility Studies: Paracetamol Manufacturing
Feasibility Studies: Paracetamol Manufacturing
 
Feasibility Studies: Tanespimycin Manufacturing
Feasibility Studies: Tanespimycin ManufacturingFeasibility Studies: Tanespimycin Manufacturing
Feasibility Studies: Tanespimycin Manufacturing
 
The long and winding road to chemical information
The long and winding road to chemical informationThe long and winding road to chemical information
The long and winding road to chemical information
 
3.L References.docx
3.L References.docx3.L References.docx
3.L References.docx
 
Med dra Basics
Med dra  BasicsMed dra  Basics
Med dra Basics
 
Straightpoint ATEX & IECEx load monitoring products for hazardous areas
Straightpoint ATEX & IECEx load monitoring products for hazardous areasStraightpoint ATEX & IECEx load monitoring products for hazardous areas
Straightpoint ATEX & IECEx load monitoring products for hazardous areas
 
Economics of TEA-Lauryl Sulfate Production Processes
Economics of TEA-Lauryl Sulfate Production ProcessesEconomics of TEA-Lauryl Sulfate Production Processes
Economics of TEA-Lauryl Sulfate Production Processes
 
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIESSUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
 
Research aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzersResearch aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzers
 
Research aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzersResearch aarkstoreenterprise clinical chemistry analyzers
Research aarkstoreenterprise clinical chemistry analyzers
 
3-ICH-guidelines-6th-Sem.pdf
3-ICH-guidelines-6th-Sem.pdf3-ICH-guidelines-6th-Sem.pdf
3-ICH-guidelines-6th-Sem.pdf
 
Economics of HMF Production Processes
Economics of HMF Production ProcessesEconomics of HMF Production Processes
Economics of HMF Production Processes
 

Mehr von ChemAxon

Translating data to predictive models
Translating data to predictive modelsTranslating data to predictive models
Translating data to predictive models
ChemAxon
 

Mehr von ChemAxon (20)

Akos Tarcsay (ChemAxon): How fast is Chemaxon RDBMS Search?
Akos Tarcsay (ChemAxon): How fast is Chemaxon RDBMS Search?Akos Tarcsay (ChemAxon): How fast is Chemaxon RDBMS Search?
Akos Tarcsay (ChemAxon): How fast is Chemaxon RDBMS Search?
 
Chemaxon EU UGM 2022 | Translating data to predictive models
Chemaxon EU UGM 2022 | Translating data to predictive modelsChemaxon EU UGM 2022 | Translating data to predictive models
Chemaxon EU UGM 2022 | Translating data to predictive models
 
Translating data to predictive models
Translating data to predictive modelsTranslating data to predictive models
Translating data to predictive models
 
Efficient biomolecular structural data handling and analysis - Webinar with D...
Efficient biomolecular structural data handling and analysis - Webinar with D...Efficient biomolecular structural data handling and analysis - Webinar with D...
Efficient biomolecular structural data handling and analysis - Webinar with D...
 
Biomolecule structural data management
Biomolecule structural data managementBiomolecule structural data management
Biomolecule structural data management
 
Cheminfo Stories 2021 | Virtual UGM | Marvin Pro: The first release
Cheminfo Stories 2021 | Virtual UGM | Marvin Pro: The first releaseCheminfo Stories 2021 | Virtual UGM | Marvin Pro: The first release
Cheminfo Stories 2021 | Virtual UGM | Marvin Pro: The first release
 
Enhanced stereochemistry representation
Enhanced stereochemistry representation Enhanced stereochemistry representation
Enhanced stereochemistry representation
 
Intellectual property (IP) intelligence solutions designed for the way resear...
Intellectual property (IP) intelligence solutions designed for the way resear...Intellectual property (IP) intelligence solutions designed for the way resear...
Intellectual property (IP) intelligence solutions designed for the way resear...
 
GPS for Chemical Space - Digital Assistants to Support Molecule Design - Chem...
GPS for Chemical Space - Digital Assistants to Support Molecule Design - Chem...GPS for Chemical Space - Digital Assistants to Support Molecule Design - Chem...
GPS for Chemical Space - Digital Assistants to Support Molecule Design - Chem...
 
Patent Data for Artificial Intelligence based Drug Discovery
Patent Data for Artificial Intelligence based Drug DiscoveryPatent Data for Artificial Intelligence based Drug Discovery
Patent Data for Artificial Intelligence based Drug Discovery
 
Cheminfo Stories APAC 2020 - Chemical Descriptors & Standardizers for Machine...
Cheminfo Stories APAC 2020 - Chemical Descriptors & Standardizers for Machine...Cheminfo Stories APAC 2020 - Chemical Descriptors & Standardizers for Machine...
Cheminfo Stories APAC 2020 - Chemical Descriptors & Standardizers for Machine...
 
Research data management on the cloud
Research data management on the cloudResearch data management on the cloud
Research data management on the cloud
 
Cheminfo Stories APAC 2020 - Introducing Design Hub & Compound Registration
Cheminfo Stories APAC 2020 - Introducing Design Hub & Compound RegistrationCheminfo Stories APAC 2020 - Introducing Design Hub & Compound Registration
Cheminfo Stories APAC 2020 - Introducing Design Hub & Compound Registration
 
Cheminfo Stories APAC 2020 - JChem Engines introduction
Cheminfo Stories APAC 2020 - JChem Engines introduction Cheminfo Stories APAC 2020 - JChem Engines introduction
Cheminfo Stories APAC 2020 - JChem Engines introduction
 
Cheminfo Stories APAC 2020 - Database management on desktop with JChem for Of...
Cheminfo Stories APAC 2020 - Database management on desktop with JChem for Of...Cheminfo Stories APAC 2020 - Database management on desktop with JChem for Of...
Cheminfo Stories APAC 2020 - Database management on desktop with JChem for Of...
 
Cheminfo Stories APAC 2020 -- Markush technology
Cheminfo Stories APAC 2020 -- Markush technology Cheminfo Stories APAC 2020 -- Markush technology
Cheminfo Stories APAC 2020 -- Markush technology
 
JChem Microservices
JChem MicroservicesJChem Microservices
JChem Microservices
 
Migration from joc to jpc or choral
Migration from joc to jpc or choralMigration from joc to jpc or choral
Migration from joc to jpc or choral
 
ChemAxon's Compliance Checker - Cheminfo Stories 2020 Day 5
ChemAxon's Compliance Checker - Cheminfo Stories 2020 Day 5ChemAxon's Compliance Checker - Cheminfo Stories 2020 Day 5
ChemAxon's Compliance Checker - Cheminfo Stories 2020 Day 5
 
Chemicalize Pro - Cheminfo Stories 2020 Day 5
Chemicalize Pro - Cheminfo Stories 2020 Day 5Chemicalize Pro - Cheminfo Stories 2020 Day 5
Chemicalize Pro - Cheminfo Stories 2020 Day 5
 

Kürzlich hochgeladen

Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Kürzlich hochgeladen (20)

[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
AI in Action: Real World Use Cases by Anitaraj
AI in Action: Real World Use Cases by AnitarajAI in Action: Real World Use Cases by Anitaraj
AI in Action: Real World Use Cases by Anitaraj
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptx
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 

EUGM 2013 - Steve Hajkowski (Thomson Reuters): Patent analytics - what can Markush data tell us?

  • 1. MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013
  • 2. THOMSON REUTERS MARKUSH DATA • Indexing for 2.4 million patent families – 1.6m Markush structures, re-drawn & stored in Thomson Reuters vmn file format – 1.98m specific compounds – plus the corresponding DWPI records – 28 patent issuing authorities covered • backfile from 1978 for US, EP and WO patents – covers pharmaceutical, agrochemical and general chemistry patents • Indexed as part of the editorial process that creates Derwent World Patents Index (DWPI) – Informative English language titles & abstracts from worldwide patents – Patent family listing, patent assignees
  • 3. COVERAGE START DATES Austria 1987 Korea 2008 Australia 1987 Malaysia 2010 Belgium 1987 Netherlands 1987 Brazil 2010 New Zealand 1987 Canada 1987 PCT/WO 1978 (Pharma); 1982 (Agro + Gen. Chem.) China 2008 Poland 2011 European Patents 1978 (Pharma); 1982 (Agro + Gen. Chem.) Russia 1993-1998 and 2010 to date France 1961-1976 (FR-M); 1978 (Pharma); 1982 (Agro + Gen Chem) South Africa 1987 Germany 1980 (Pharma); 1983-84 and 1987 to date (Agro + Gen. Chem.) Spain 2010 Great Britain 1980 (Pharma); 1983-84 and 1987 to date (Agro + Gen. Chem.) Sweden 1987 Gulf Cooperation Council 2008 Switzerland 1987 India 2000 Thailand 2010 Ireland 1987 United States 1978 (Pharma); 1982 (Agro + Gen. Chem.) Japan 1987 Vietnam 2010
  • 4. MARKUSH DATA ACCESS • Markush structure data available alongside corresponding specific compounds & DWPI records • Load into ChemAxon’s JChem database tools • Resulting solution gives access to full chemistry & patents dataset – data can be searched, enumerated & integrated into the customer’s own systems & workflows 4
  • 5. JCHEM MARKUSH BENEFITS • Structure data displayed alongside high quality patent summaries from DWPI – includes abstract, patent assignee, patent family, activities & mechanisms of action • Time saving visualisation and enumeration capabilities enable fast relevance analysis of hit structures/patents • Enumerated structures are in standard format allowing easy integration with other chemistry datasets/tools
  • 6. USE CASES • Novelty searching by IP departments – Easy assessment of structural proximity of query structure to hit Markush • Screening of new structures against existing IP • Potential use in white-space identification, patent busting etc. • Creation of libraries of specifics for use in other systems
  • 7. MARKUSH PATENT ANALYSIS • What can analysis of Markush and DWPI patent data tell us about global patenting trends in 2012? • > 8000 patents claiming new pharmaceutical Markush structures • > 3700 patents claiming new non-pharma Markush structures
  • 8. MARKUSH PHARMA PATENTING COMPANIES 2012 Number of patents Company 129 MERCK & CO 119 ROCHE 82 BAYER AG 60 ABBOTT 59 GLAXOSMITHKLINE 57 NOVARTIS 57 CENTRE NATIONAL RECHERCHE SCIENTIFIQUE 55 BOEHRINGER INGELHEIM 54 SANOFI AVENTIS 52 BRISTOL-MYERS SQUIBB 51 MERCK PATENT GMBH 42 JOHNSON & JOHNSON 41 ALLERGAN 39 TAKEDA PHARMA 37 PFIZER 30 COUNCIL SCI&IND RES INDIA 27 SHIONOGI 26 DAIICHI SANKYO 25 UNIV CALIFORNIA
  • 10. MARKUSH CHEMICAL PATENTING COMPANIES 2012 Number of patents Company 164 SUMITOMO CHEMICAL CO 90 BAYER CROPSCIENCE 82 BASF 65 MERCK PATENT GMBH 61 FUJI FILM CO 42 SEMICONDUCTOR ENERGY LAB 40 SYNGENTA 39 ROHM&HAAS ELECTRONIC MATERIALS KOREA 38 CANON KK 38 OCEANS KING LIGHTING SCI&TECHNOLOGY CO 37 IDEMITSU KOSAN CO LTD 36 DU PONT 34 HAIYANGWANG LIGHTING TECHNOLOGY CO LTD 34 NIPPON KAYAKU KK 34 POLITECHNIKA WROCLAWSKA 30 JNC CORP 28 KOREA RES INST CHEM TECHNOLOGY 27 TOSOH CORP 26 TIANJIN DEKAI CHEM LTD
  • 12. MARKUSH CASE STUDY • Analysis of all Markush patents claiming new molecules containing the structure fragment below – look at companies, timeframes, activities, inventors
  • 13. SEARCH RESULTS • A structure search of the Thomson Reuters data generates hits from 122 patents, with hits found back to 1988
  • 14. SAMPLE HITS New heterocyclic derivatives useful for treating cardiovascular diseases,hypertension, ischemic heart disease, atherosclerosis and metabolic syndrome CTG PHARMA SRL WO2008122356A1 20081016 Novel benzyloxymethyl-4-chloro-imidazol methyl-biphenyl-tetrazole group containing compound useful for treating diseases associated withperoxisome proliferator-activated receptor-gamma, e.g. diabetes and angiocardiopathy SHANGHAI AILISI MEDICINE SCI & TECHNOLOGY WO2008110062A1 20080918
  • 15. SAMPLE HITS New 2-butyl-4-chloro-imidazol-5-yl-methyl ester compound used for preparing drugs for prophylaxis and/or treating high blood pressure or correlative diseases including pulmonary arterial hypertension, coronary heart disease and/or migraine WANG J CN101475565A 20090708 Forming biphenyltetrazole derivatives useful to treat e.g. stroke involves reacting 2-(trimethylsilyl)ethoxymethyl protected biphenyltetrazole compounds with nucleophilic reagent and subsequent deprotection ofprotecting group SIMS SOC ITAL MEDICINALI SCANDICCI SRL WO--2008012852A1
  • 16. TOP 10 COMPANIES Number of patents Company 17 MERCK & CO INC 8 NICOX SA 7 DU PONT DE NEMOURS & CO 7 KOTOBUKI SEIYAKU CO LTD 6 MERCK PATENT GMBH 4 NITROMED INC 4 TANABE SEIYAKU CO 4 THERAVANCE INC 3 DIPHARMA SPA 3 SANKYO CO LTD
  • 19. DRUG ACTIVITIES CLAIMED % of Patents Activity 88 Hypotensive 64 Cardioactive 47 Renal active 43 Anti-cholesterol 43 Eye preparations 34 Circulatory active 32 Antipsychotic 30 Coronary dilator 28 Antimetabolite 27 Antiinflammatory 25 Enzyme inhibitor
  • 20. TOP INVENTORS AT MERCK Number of patents Inventor 9 LO M M 8 ALI A 6 ALMIRANTE N 5 STEFANINI S 4 BIONDI S 4 CHAKRAVARTY P K 4 FRANKLIN C 4 GREENLEE W J 4 NARGUND R P 4 PATCHETT A A 4 SEBHAT I K
  • 21. SUMMARY • Markush analysis allows us to view the chemistry patent lansdcape – broad view of trends for companies, countries etc – narrower view for particular structure types • shows which companies are active, trends over time, top inventors, drug activities etc.